Global Animal-derived Immune Globulin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Get access now!

Global Animal-derived Immune Globulin Market Trends and Opportunities 2025-31

The global Animal-derived Immune Globulin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from 2.6bn in 2015 to 4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on Chinas Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of Chinas pet medical market is about 67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 228%. Infinity Market Research newest research report, the Animal-derived Immune Globulin Industry Forecast looks at past sales and reviews total world Animal-derived Immune Globulin sales in 2024, providing a comprehensive analysis by region and market sector of projected Animal-derived Immune Globulin sales for 2025 through 2031. With Animal-derived Immune Globulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Animal-derived Immune Globulin industry. This Insight Report provides a comprehensive analysis of the global Animal-derived Immune Globulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Animal-derived Immune Globulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Animal-derived Immune Globulin market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Animal-derived Immune Globulin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Animal-derived Immune Globulin. This report presents a comprehensive overview, market shares, and growth opportunities of Animal-derived Immune Globulin market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Liquid &nbsp;&nbsp;&nbsp; Powder Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Clinic This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Rare Disease Therapeutics &nbsp;&nbsp;&nbsp; Merck &nbsp;&nbsp;&nbsp; Sanofi &nbsp;&nbsp;&nbsp; Wyeth Pharmaceuticals &nbsp;&nbsp;&nbsp; Protherics &nbsp;&nbsp;&nbsp; Genzyme Key Questions Addressed in this Report What is the 10-year outlook for the global Animal-derived Immune Globulin market? What factors are driving Animal-derived Immune Globulin market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Animal-derived Immune Globulin market opportunities vary by end market size? How does Animal-derived Immune Globulin break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Animal-derived Immune Globulin Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Animal-derived Immune Globulin by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Animal-derived Immune Globulin by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Animal-derived Immune Globulin Segment by Type &nbsp;2.2.1 Liquid &nbsp;2.2.2 Powder &nbsp;2.3 Animal-derived Immune Globulin Sales by Type &nbsp;2.3.1 Global Animal-derived Immune Globulin Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Animal-derived Immune Globulin Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Animal-derived Immune Globulin Sale Price by Type (2020-2025) &nbsp;2.4 Animal-derived Immune Globulin Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Clinic &nbsp;2.5 Animal-derived Immune Globulin Sales by Application &nbsp;2.5.1 Global Animal-derived Immune Globulin Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Animal-derived Immune Globulin Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Animal-derived Immune Globulin Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Animal-derived Immune Globulin Breakdown Data by Company &nbsp;3.1.1 Global Animal-derived Immune Globulin Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Animal-derived Immune Globulin Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Animal-derived Immune Globulin Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Animal-derived Immune Globulin Revenue by Company (2020-2025) &nbsp;3.2.2 Global Animal-derived Immune Globulin Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Animal-derived Immune Globulin Sale Price by Company &nbsp;3.4 Key Manufacturers Animal-derived Immune Globulin Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Animal-derived Immune Globulin Product Location Distribution &nbsp;3.4.2 Players Animal-derived Immune Globulin Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Animal-derived Immune Globulin by Geographic Region &nbsp;4.1 World Historic Animal-derived Immune Globulin Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Animal-derived Immune Globulin Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Animal-derived Immune Globulin Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Animal-derived Immune Globulin Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Animal-derived Immune Globulin Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Animal-derived Immune Globulin Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Animal-derived Immune Globulin Sales Growth &nbsp;4.4 APAC Animal-derived Immune Globulin Sales Growth &nbsp;4.5 Europe Animal-derived Immune Globulin Sales Growth &nbsp;4.6 Middle East & Africa Animal-derived Immune Globulin Sales Growth 5 Americas &nbsp;5.1 Americas Animal-derived Immune Globulin Sales by Country &nbsp;5.1.1 Americas Animal-derived Immune Globulin Sales by Country (2020-2025) &nbsp;5.1.2 Americas Animal-derived Immune Globulin Revenue by Country (2020-2025) &nbsp;5.2 Americas Animal-derived Immune Globulin Sales by Type (2020-2025) &nbsp;5.3 Americas Animal-derived Immune Globulin Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Animal-derived Immune Globulin Sales by Region &nbsp;6.1.1 APAC Animal-derived Immune Globulin Sales by Region (2020-2025) &nbsp;6.1.2 APAC Animal-derived Immune Globulin Revenue by Region (2020-2025) &nbsp;6.2 APAC Animal-derived Immune Globulin Sales by Type (2020-2025) &nbsp;6.3 APAC Animal-derived Immune Globulin Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Animal-derived Immune Globulin by Country &nbsp;7.1.1 Europe Animal-derived Immune Globulin Sales by Country (2020-2025) &nbsp;7.1.2 Europe Animal-derived Immune Globulin Revenue by Country (2020-2025) &nbsp;7.2 Europe Animal-derived Immune Globulin Sales by Type (2020-2025) &nbsp;7.3 Europe Animal-derived Immune Globulin Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Animal-derived Immune Globulin by Country &nbsp;8.1.1 Middle East & Africa Animal-derived Immune Globulin Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Animal-derived Immune Globulin Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Animal-derived Immune Globulin Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Animal-derived Immune Globulin Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Animal-derived Immune Globulin &nbsp;10.3 Manufacturing Process Analysis of Animal-derived Immune Globulin &nbsp;10.4 Industry Chain Structure of Animal-derived Immune Globulin 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Animal-derived Immune Globulin Distributors &nbsp;11.3 Animal-derived Immune Globulin Customer 12 World Forecast Review for Animal-derived Immune Globulin by Geographic Region &nbsp;12.1 Global Animal-derived Immune Globulin Market Size Forecast by Region &nbsp;12.1.1 Global Animal-derived Immune Globulin Forecast by Region (2026-2031) &nbsp;12.1.2 Global Animal-derived Immune Globulin Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Animal-derived Immune Globulin Forecast by Type (2026-2031) &nbsp;12.7 Global Animal-derived Immune Globulin Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Pfizer &nbsp;13.1.1 Pfizer Company Information &nbsp;13.1.2 Pfizer Animal-derived Immune Globulin Product Portfolios and Specifications &nbsp;13.1.3 Pfizer Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Pfizer Main Business Overview &nbsp;13.1.5 Pfizer Latest Developments &nbsp;13.2 Rare Disease Therapeutics &nbsp;13.2.1 Rare Disease Therapeutics Company Information &nbsp;13.2.2 Rare Disease Therapeutics Animal-derived Immune Globulin Product Portfolios and Specifications &nbsp;13.2.3 Rare Disease Therapeutics Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Rare Disease Therapeutics Main Business Overview &nbsp;13.2.5 Rare Disease Therapeutics Latest Developments &nbsp;13.3 Merck &nbsp;13.3.1 Merck Company Information &nbsp;13.3.2 Merck Animal-derived Immune Globulin Product Portfolios and Specifications &nbsp;13.3.3 Merck Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Merck Main Business Overview &nbsp;13.3.5 Merck Latest Developments &nbsp;13.4 Sanofi &nbsp;13.4.1 Sanofi Company Information &nbsp;13.4.2 Sanofi Animal-derived Immune Globulin Product Portfolios and Specifications &nbsp;13.4.3 Sanofi Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Sanofi Main Business Overview &nbsp;13.4.5 Sanofi Latest Developments &nbsp;13.5 Wyeth Pharmaceuticals &nbsp;13.5.1 Wyeth Pharmaceuticals Company Information &nbsp;13.5.2 Wyeth Pharmaceuticals Animal-derived Immune Globulin Product Portfolios and Specifications &nbsp;13.5.3 Wyeth Pharmaceuticals Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Wyeth Pharmaceuticals Main Business Overview &nbsp;13.5.5 Wyeth Pharmaceuticals Latest Developments &nbsp;13.6 Protherics &nbsp;13.6.1 Protherics Company Information &nbsp;13.6.2 Protherics Animal-derived Immune Globulin Product Portfolios and Specifications &nbsp;13.6.3 Protherics Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Protherics Main Business Overview &nbsp;13.6.5 Protherics Latest Developments &nbsp;13.7 Genzyme &nbsp;13.7.1 Genzyme Company Information &nbsp;13.7.2 Genzyme Animal-derived Immune Globulin Product Portfolios and Specifications &nbsp;13.7.3 Genzyme Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Genzyme Main Business Overview &nbsp;13.7.5 Genzyme Latest Developments 14 Research Findings and Conclusion

Report	Global Animal-derived Immune Globulin Market Growth 2025-2031
Selected License	Single ID:LPI21426

Buyer Information

Order Summary